Alogliptin and voglibose

DRUG2 trials

Sponsors

Takeda

Conditions

Type 2 Diabetes Mellitus

Phase 2

Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

CompletedNCT01263509

TakedaType 2 Diabetes Mellitus

Start: 2007-06-30End: 2008-10-31Updated: 2012-02-03

Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

CompletedNCT01263483

TakedaType 2 Diabetes Mellitus

Start: 2007-01-31End: 2008-04-30Updated: 2012-02-03

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01

Alogliptin plus voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension.

2011-11-0142 citations